Onconova Therapeutics on Thursday said it will collaborate with Pangea Biomed to identify biomarkers of response to Onconova’s cancer drug candidate rigosertib.
Back
Back
Onconova Therapeutics on Thursday said it will collaborate with Pangea Biomed to identify biomarkers of response to Onconova’s cancer drug candidate rigosertib.